eCite Digital Repository

TGR5 contributes to ursodeoxycholic acid (UDCA)-mediated improvements in glucose regulation in mice


Jayasinghe, S and Garibay, D and Chouinard, T and Cummings, B, TGR5 contributes to ursodeoxycholic acid (UDCA)-mediated improvements in glucose regulation in mice, 2017 Keystone Symposia Conference, 3 - 7 March 2017, Monterey, California (2017) [Conference Extract]

Pending copyright assessment - Request a copy


Bile acids (BAs) are amphipathic steroid derivatives, whose primary action is the solubilization of dietary lipids. However, BAs also play a critical role in glucose regulation. Numerous subtypes of BAs exist and they exhibit wide variation in their impact on glucose regulation. In particular, the BA subtype UDCA improves insulin sensitivity by decreasing endoplasmic reticulum (ER) stress and thus has been described as a "chemical chaperone." The mechanism by which UDCA decreases ER stress and improves insulin sensitivity remains undefined. BAs signaling through Farnesoid X receptor (FXR) and TGR5 has been shown to improve glucose homeostasis. However, UDCA is an agonist for TGR5, but not FXR. TGR5 is a transmembrane G-protein coupled receptor with potent glucoregulatory benefits. Furthermore, as a hydrophilic BA subtype, UDCA is more likely to signal through a membrane-bound receptor than a nuclear receptor. Therefore, we tested the hypothesis that TGR5 contributes to the glucoregulatory benefits of UDCA supplementation. Tgr5+/+ (WT) and Tgr5-/- (KO) mice received high fat diet (HFD) with (WT UDCA, KO UDCA) and without (WT CON, KO CON) UDCA supplementation (n=8-10 per group). UDCA-treated mice received UDCA mixed in the diet such that animals consumed 150 mg/kg/d UDCA. Body weight, food intake and adiposity did not differ between groups. During and oral glucose tolerance test (OGTT), UDCA improved glucose tolerance in Tgr5+/+ but not in Tgr5-/- mice (Glucose AUC (mg/dl x 120 min): WT CON = 389912080, WT UDCA = 33961917, KO CON = 34394954, KO UDCA = 367592800; P<0.05 WT CON vs WT UDCA). Insulin and glucagon-like peptide-1 (GLP-1) secretion did not differ between groups. Together, our data show that TGR5 contributes to the glucoregulatory benefits of UDCA treatment, independently of GLP-1.

Item Details

Item Type:Conference Extract
Keywords:glucose regulation, bile acid
Research Division:Biological Sciences
Research Group:Biochemistry and cell biology
Research Field:Systems biology
Objective Division:Health
Objective Group:Specific population health (excl. Indigenous health)
Objective Field:Neonatal and child health
UTAS Author:Jayasinghe, S (Dr Sisitha Jayasinghe)
ID Code:146887
Year Published:2017
Deposited By:Health Sciences
Deposited On:2021-10-01
Last Modified:2021-11-24

Repository Staff Only: item control page